{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:39:07Z","timestamp":1783399147563,"version":"3.54.6"},"reference-count":145,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"DOI":"10.2146\/ajhp110014","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T19:33:21Z","timestamp":1326915201000},"page":"199-212","source":"Crossref","is-referenced-by-count":66,"title":["Antidotes for toxicological emergencies: A practical review"],"prefix":"10.1093","volume":"69","author":[{"given":"Jeanna M.","family":"Marraffa","sequence":"first","affiliation":[{"name":"Upstate New York Poison Center, Syracuse, and Assistant Professor, Department of Emergency Medicine, State University of New York Upstate Medical University, Syracuse."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Cohen","sequence":"additional","affiliation":[{"name":"Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, and Clinical Pharmacy Manager, Maimonides Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Howland","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Allied Health Professions, St. John\u2019s University, Queens, NY; Adjunct Professor of Emergency Medicine, New York University (NYU) School of Medicine, New York, and Senior Consultant in Residence, New York City Poison Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041606593274700_b1-0690199","first-page":"93","article-title":"Unintentional poisoning deaths\u2014United States, 1999\u20132004","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2019041606593274700_b2-0690199","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/15563650.2010.543906","article-title":"2009 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 27th annual report","volume":"48","author":"Bronstein","year":"2010","journal-title":"Clin Toxicol (Phila)."},{"key":"2019041606593274700_b3-0690199","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/S0196-0644(05)80408-1","article-title":"Poisoning deaths not reported to the regional poison center","volume":"22","author":"Linakis","year":"1993","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b4-0690199","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archpedi.152.12.1181","article-title":"Accidental and suicidal adolescent poisoning deaths in the US, 1979\u20131994","volume":"152","author":"Shepherd","year":"1998","journal-title":"Arch Pediatr Adolesc Med."},{"key":"2019041606593274700_b5-0690199","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.annemergmed.2009.01.023","article-title":"Antidote Summit Authorship G. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care","volume":"54","author":"Dart","year":"2009","journal-title":"Ann Emerg Med"},{"key":"2019041606593274700_b6-0690199","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM200102083440605","article-title":"Fomepizole for the treatment of methanol poisoning","volume":"344","author":"Brent","year":"2001","journal-title":"N Engl J Med."},{"key":"2019041606593274700_b7-0690199","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199903183401102","article-title":"Fomepizole for the treatment of ethylene glycol poisoning","volume":"340","author":"Brent","year":"1999","journal-title":"N Engl J Med."},{"key":"2019041606593274700_b8-0690199","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1081\/CLT-120006745","article-title":"American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning","volume":"40","author":"Barceloux","year":"2002","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606593274700_b9-0690199","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650903438566","article-title":"2008 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 26th annual report","volume":"47","author":"Bronstein","year":"2009","journal-title":"Clin Toxicol (Phila)."},{"key":"2019041606593274700_b10-0690199","first-page":"450","article-title":"Pharmacokinetics of fomepizole (4MP) in patients","volume":"36","author":"McMartin","year":"1998","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606593274700_b11-0690199","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/15563650.2011.556642","article-title":"Outcomes of visual disturbances after methanol poisoning","volume":"49","author":"Sanaei-Zadeh","year":"2011","journal-title":"Clin Toxicol."},{"key":"2019041606593274700_b12-0690199","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM198901123200215","article-title":"Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole","volume":"320","author":"McMartin","year":"1989","journal-title":"N Engl J Med."},{"key":"2019041606593274700_b13-0690199","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.311.6997.88","article-title":"Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic","volume":"311","author":"Hanif","year":"1995","journal-title":"BMJ."},{"key":"2019041606593274700_b14-0690199","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/02724936.1992.11747577","article-title":"Diethylene glycol poisoning in Nigerian children","volume":"12","author":"Okuonghae","year":"1992","journal-title":"Ann Trop Paediatr."},{"key":"2019041606593274700_b15-0690199","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1212\/01.WNL.0000032498.65787.8D","article-title":"Fulminant ascending paralysis as a delayed sequela of diethylene glycol (Sterno) ingestion","volume":"59","author":"Rollins","year":"2002","journal-title":"Neurology."},{"key":"2019041606593274700_b16-0690199","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jemermed.2007.06.025","article-title":"Diethylene glycol: widely used solvent presents serious poisoning potential","volume":"35","author":"Marraffa","year":"2007","journal-title":"J Emerg Med."},{"key":"2019041606593274700_b17-0690199","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/01.WNL.0000156804.07265.1A","article-title":"Encephalopathy and peripheral neuropathy following diethylene glycol ingestion","volume":"64","author":"Hasbani","year":"2005","journal-title":"Neurology."},{"key":"2019041606593274700_b18-0690199","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/CLT-57875","article-title":"Delayed neurologic sequelae resulting from epidemic diethylene glycol poisoning","volume":"43","author":"Alfred","year":"2005","journal-title":"Clin Toxicol (Phila)."},{"key":"2019041606593274700_b19-0690199","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/tropej\/fml040","article-title":"Fatal encephalopathy and renal failure caused by diethylene glycol poisoning","volume":"52","author":"Hari","year":"2006","journal-title":"J Trop Pediatr."},{"key":"2019041606593274700_b20-0690199","first-page":"374","article-title":"Diglycolic acid is the nephrotoxic metabolite in diethylene glycol poisoning inducing necrosis in human proximal tubule cells in vitro","volume":"123","author":"Landry","year":"2011","journal-title":"Toxicol Sci."},{"key":"2019041606593274700_b21-0690199","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/15563659709001182","article-title":"Antidotes for methanol and ethylene glycol poisoning","volume":"35","author":"Jacobsen","year":"1997","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606593274700_b22-0690199","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00007691-200406000-00006","article-title":"Plasma and tissue determination of 4-methylpyrazole for pharmacokinetic analysis in acute adult and pediatric methanol\/ethylene glycol poisoning","volume":"26","author":"Wallemacq","year":"2004","journal-title":"Ther Drug Monit."},{"key":"2019041606593274700_b23-0690199","volume-title":"Antizol (fomepizole) injection product information","year":"2007"},{"key":"2019041606593274700_b24-0690199","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1530-0277.1980.tb04835.x","article-title":"Methanol toxicity: treatment with folic acid and 5-formyl tetrahydrofolic acid","volume":"4","author":"Noker","year":"1980","journal-title":"Alcohol Clin Exp Res."},{"key":"2019041606593274700_b25-0690199","first-page":"305","article-title":"The role of folates in methanol toxicity","volume":"132","author":"Noker","year":"1980","journal-title":"Adv Exp Med Biol."},{"key":"2019041606593274700_b26-0690199","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.1990.tb28060.x","article-title":"Role of pyridoxine in oxalate metabolism","volume":"585","author":"Nath","year":"1990","journal-title":"Ann N Y Acad Sci."},{"key":"2019041606593274700_b27-0690199","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000177576","article-title":"Comparative studies on the effect of vitamin A, B1 and B6 deficiency on oxalate metabolism in male rats","volume":"34","author":"Sharma","year":"1990","journal-title":"Ann Nutr Metab."},{"key":"2019041606593274700_b28-0690199","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.emc.2007.02.001","article-title":"Management of beta-adrenergic blocker and calcium channel antagonist toxicity","volume":"25","author":"Kerns","year":"2007","journal-title":"Emerg Med Clin North Am."},{"key":"2019041606593274700_b29-0690199","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00139709-200423040-00003","article-title":"Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity","volume":"23","author":"DeWitt","year":"2004","journal-title":"Toxicol Rev."},{"key":"2019041606593274700_b30-0690199","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/01.CCM.0000278916.04569.23","article-title":"Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil","volume":"35","author":"Levine","year":"2007","journal-title":"Crit Care Med."},{"key":"2019041606593274700_b31-0690199","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00006565-200202000-00012","article-title":"Hyperinsulinemia\/euglycemia therapy for calcium channel blocker poisoning","volume":"18","author":"Boyer","year":"2002","journal-title":"Pediatr Emerg Care."},{"key":"2019041606593274700_b32-0690199","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1081\/CLT-100102437","article-title":"Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning","volume":"37","author":"Yuan","year":"1999","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606593274700_b33-0690199","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0024-3205(81)90457-4","article-title":"The actions of insulin on cardiac contractility","volume":"29","author":"Farah","year":"1981","journal-title":"Life Sci."},{"key":"2019041606593274700_b34-0690199","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00139709-200423040-00002","article-title":"The role of insulin and glucose (hyperinsulinaemia\/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning","volume":"23","author":"M\u00e9garbane","year":"2004","journal-title":"Toxicol Rev."},{"key":"2019041606593274700_b35-0690199","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc4938","article-title":"Bench-to-bedside review: hyperinsulinaemia\/euglycaemia therapy in the management of overdose of calcium-channel blockers","volume":"10","author":"Lheureux","year":"2006","journal-title":"Crit Care."},{"key":"2019041606593274700_b36-0690199","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/00003246-199507000-00016","article-title":"Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine","volume":"23","author":"Kline","year":"1995","journal-title":"Crit Care Med."},{"key":"2019041606593274700_b37-0690199","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3565(25)39488-7","article-title":"Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine","volume":"267","author":"Kline","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"2019041606593274700_b38-0690199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1996.0051","article-title":"The effects of extracellular ions on beta-blocker cardiotoxicity","volume":"137","author":"Kerns","year":"1996","journal-title":"Toxicol Appl Pharmacol."},{"key":"2019041606593274700_b39-0690199","first-page":"893","volume-title":"Antidotes in depth: insulin-euglycemia therapy","author":"Kerns","year":"2011","edition":"9th ed"},{"key":"2019041606593274700_b40-0690199","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/15563650.2011.582471","article-title":"High dose insulin therapy in beta-blocker and calcium channel blocker poisoning","volume":"49","author":"Engebretsen","year":"2011","journal-title":"Clin Toxicol."},{"key":"2019041606593274700_b41-0690199","volume-title":"Cyanide antidote kit (sodium nitrite injection, sodium theosulfate injection, amyl nitrite inhalants) package insert","year":"2008"},{"key":"2019041606593274700_b42-0690199","volume-title":"Nithiodote (sodium nitrite injection and sodium thiosulfate injection) package insert","year":"2011"},{"key":"2019041606593274700_b43-0690199","volume-title":"Cyanokit (hydroxocobalamin for injection) product information","year":"2009"},{"key":"2019041606593274700_b44-0690199","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00004630-199401000-00010","article-title":"Cyanide poisoning in victims of fire: analysis of 364 cases and review of the literature","volume":"15","author":"Barillo","year":"1994","journal-title":"J Burn Care Rehabil."},{"key":"2019041606593274700_b45-0690199","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1017\/S1049023X00015909","article-title":"Focus on smoke inhalation\u2014the most common cause of acute cyanide poisoning","volume":"21","author":"Eckstein","year":"2006","journal-title":"Pre-hospital Disaster Med."},{"key":"2019041606593274700_b46-0690199","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jemermed.2008.04.040","article-title":"Hydroxocobalamin for poisoning caused by ingestion of potassium cyanide: a case study","volume":"39","author":"Fortin","year":"2010","journal-title":"J Emerg Med."},{"key":"2019041606593274700_b47-0690199","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1097\/00003246-200209000-00015","article-title":"Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning","volume":"30","author":"Baud","year":"2002","journal-title":"Crit Care Med."},{"key":"2019041606593274700_b48-0690199","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.1933.02740240016005","article-title":"Amyl nitrite and cyanide poisoning","volume":"100","author":"Chen","year":"1933","journal-title":"JAMA."},{"key":"2019041606593274700_b49-0690199","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.1952.02930190015004","article-title":"Nitrite and thiosulfate therapy in cyanide poisoning","volume":"149","author":"Chen","year":"1952","journal-title":"JAMA."},{"key":"2019041606593274700_b50-0690199","first-page":"3","article-title":"Suspected cyanide poisoning in smoke inhalation and complications of sodium nitrite therapy","volume":"9","author":"Hall","year":"1989","journal-title":"J Toxicol Clin Exp."},{"key":"2019041606593274700_b51-0690199","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF00570133","article-title":"Ferrihaemoglobin formation by amyl nitrite and sodium nitrite indifferent species in vivo and in vitro","volume":"62","author":"Klimmek","year":"1988","journal-title":"Arch Toxicol."},{"key":"2019041606593274700_b52-0690199","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1213\/00000539-199705000-00031","article-title":"Prevention of fetal and maternal cyanide toxicity from nitroprusside with coin-fusion of sodium thiosulfate in gravid ewes","volume":"84","author":"Curry","year":"1997","journal-title":"Anesth Analg."},{"key":"2019041606593274700_b53-0690199","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajem.2006.10.010","article-title":"Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation","volume":"25","author":"Borron","year":"2007","journal-title":"Am J Emerg Med."},{"issue":"(suppl 1)","key":"2019041606593274700_b54-0690199","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/15563650600811870","article-title":"Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris fire brigade","volume":"44","author":"Fortin","year":"2006","journal-title":"Clin Toxicol (Phila)."},{"issue":"(suppl 1)","key":"2019041606593274700_b55-0690199","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/15563650600811672","article-title":"Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs","volume":"44","author":"Borron","year":"2006","journal-title":"Clin Toxicol (Phila)."},{"issue":"(suppl 1)","key":"2019041606593274700_b56-0690199","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15563650600811755","article-title":"Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study","volume":"44","author":"Uhl","year":"2006","journal-title":"Clin Toxicol (Phila)."},{"key":"2019041606593274700_b57-0690199","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13181-010-0067-9","article-title":"Hemodialysis complications of hydroxocobalamin: a case report","volume":"6","author":"Sutter","year":"2010","journal-title":"J Med Toxicol."},{"key":"2019041606593274700_b58-0690199","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1503\/cmaj.080727","article-title":"Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning","volume":"180","author":"Cescon","year":"2009","journal-title":"CMAJ."},{"key":"2019041606593274700_b59-0690199","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0196-0644(94)70164-4","article-title":"Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies","volume":"24","author":"Curry","year":"1994","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b60-0690199","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/clinchem\/40.11.2120","article-title":"Hydroxocobalamin and sodium thiosulfate interfere negatively with measurement of creatine kinase activity","volume":"40","author":"Beaudeux","year":"1994","journal-title":"Clin Chem."},{"key":"2019041606593274700_b61-0690199","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.semdp.2008.12.008","article-title":"Laboratory interferences with the newer cyanide antidote: hydroxocobalamin","volume":"26","author":"Beckerman","year":"2009","journal-title":"Semin Diagn Pathol."},{"key":"2019041606593274700_b62-0690199","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2008.11.007","article-title":"Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements","volume":"401","author":"Pamidi","year":"2009","journal-title":"Clin Chim Acta."},{"key":"2019041606593274700_b63-0690199","first-page":"853","article-title":"Deaths associated with a purported aphrodisiac\u2014New York City, February 1993\u2013May 1995","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2019041606593274700_b64-0690199","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0735-1097(10)80170-6","article-title":"Digoxin immune fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study","volume":"17","author":"Hickey","year":"1991","journal-title":"J Am Coll Cardiol."},{"issue":"2, suppl 1","key":"2019041606593274700_b65-0690199","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0735-6757(91)90162-D","article-title":"Results of multicenter studies of digoxin-specific antibody fragments in managing digitalis intoxication in the pediatric population","volume":"9","author":"Woolf","year":"1991","journal-title":"Am J Emerg Med."},{"key":"2019041606593274700_b66-0690199","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1161\/01.CIR.81.6.1744","article-title":"Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific fab antibody fragments. Final report of a multicenter study","volume":"81","author":"Antman","year":"1990","journal-title":"Circulation."},{"key":"2019041606593274700_b67-0690199","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00134-008-1092-x","article-title":"Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure","volume":"34","author":"Lapostolle","year":"2008","journal-title":"Intensive Care Med."},{"key":"2019041606593274700_b68-0690199","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1097\/CCM.0b013e31818b341c","article-title":"Digoxin-specific fab fragments as single first-line therapy in digitalis poisoning","volume":"36","author":"Lapostolle","year":"2008","journal-title":"Crit Care Med."},{"key":"2019041606593274700_b69-0690199","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJM199809173391204","article-title":"Contamination of botanical dietary supplements by digitalis lanata","volume":"339","author":"Slifman","year":"1998","journal-title":"N Engl J Med."},{"key":"2019041606593274700_b70-0690199","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/096032719701601009","article-title":"Immunotoxicotherapy: successes, disappointments and hopes","volume":"16","author":"Bismuth","year":"1997","journal-title":"Hum Exp Toxicol."},{"key":"2019041606593274700_b71-0690199","first-page":"3827","article-title":"Digitoxin poisoning: reversing ventricular fibrillation with fab fragments of anti-digoxin antibody","volume":"11","author":"Domart","year":"1982","journal-title":"Nouv Presse Med."},{"key":"2019041606593274700_b72-0690199","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/15563658508990641","article-title":"Digoxin specific antibody (fab) fragments in 34 cases of severe digitalis intoxication","volume":"23","author":"Smolarz","year":"1985","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606593274700_b73-0690199","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2165\/00002512-199710010-00003","article-title":"Advances in the management of digoxin toxicity in the older patient","volume":"10","author":"Borron","year":"1997","journal-title":"Drugs Aging."},{"key":"2019041606593274700_b74-0690199","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-66-1-116","article-title":"The distribution and concentration of tritiated digoxin in human tissues","volume":"66","author":"Doherty","year":"1967","journal-title":"Ann Intern Med."},{"key":"2019041606593274700_b75-0690199","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2125.1983.tb02194.x","article-title":"Plasma digoxin: assay anomalies in Fab-treated patients","volume":"16","author":"Gibb","year":"1983","journal-title":"Br J Clin Pharmacol."},{"key":"2019041606593274700_b76-0690199","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1553-2712.1997.tb03653.x","article-title":"Flumazenil: a pharmacologic antidote with limited medical toxicology utility, or . . . an antidote in search of an overdose","volume":"4","author":"Goldfrank","year":"1997","journal-title":"Acad Emerg Med."},{"key":"2019041606593274700_b77-0690199","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/106002809402801204","article-title":"Fatal seizures after flumazenil administration in a patient with mixed overdose","volume":"28","author":"Haverkos","year":"1994","journal-title":"Ann Pharmacother."},{"key":"2019041606593274700_b78-0690199","first-page":"43","article-title":"Risks of flumazenil in mixed benzodiazepine-tricyclic antidepressant overdose: report of a preliminary study in the dog","volume":"12","author":"Lheureux","year":"1992","journal-title":"J Toxicol Clin Exp."},{"key":"2019041606593274700_b79-0690199","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/00003246-199212000-00022","article-title":"Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose","volume":"20","author":"Mordel","year":"1992","journal-title":"Crit Care Med."},{"key":"2019041606593274700_b80-0690199","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1081\/CLT-120030946","article-title":"Flumazenil\u2014treatment or toxin","volume":"42","author":"Seger","year":"2004","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606593274700_b81-0690199","first-page":"2","volume-title":"AHFS drug information 2009","author":"McEvoy","year":"2009"},{"key":"2019041606593274700_b82-0690199","volume-title":"Romazicon (flumazenil) injection product information","year":"2007"},{"key":"2019041606593274700_b83-0690199","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00139709-200625030-00001","article-title":"Lipid rescue resuscitation from local anaesthetic cardiac toxicity","volume":"25","author":"Weinberg","year":"2006","journal-title":"Toxicol Rev."},{"key":"2019041606593274700_b84-0690199","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00000542-200607000-00005","article-title":"Lipid infusion resuscitation for local anesthetic toxicity: proof of clinical efficacy","volume":"105","author":"Weinberg","year":"2006","journal-title":"Anesthesiology."},{"key":"2019041606593274700_b85-0690199","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00115550-200305000-00005","article-title":"Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity","volume":"28","author":"Weinberg","year":"2003","journal-title":"Reg Anesth Pain Med."},{"key":"2019041606593274700_b86-0690199","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1213\/ane.0b013e31819a8917","article-title":"Limits to lipid in the literature and lab: what we know, what we don\u2019t know","volume":"108","author":"Weinberg","year":"2009","journal-title":"Anesth Analg."},{"key":"2019041606593274700_b87-0690199","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1213\/ane.0b013e31816a6c09","article-title":"Lipid infusion therapy: translation to clinical practice","volume":"106","author":"Weinberg","year":"2008","journal-title":"Anesth Analg."},{"key":"2019041606593274700_b88-0690199","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/ALN.0b013e31816d91d2","article-title":"Resuscitation with lipid versus epinephrine in a rat model of bupivacaine overdose","volume":"108","author":"Weinberg","year":"2008","journal-title":"Anesthesiology."},{"key":"2019041606593274700_b89-0690199","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/ALN.0b013e3181afde0a","article-title":"Epinephrine impairs lipid resuscitation from bupivacaine overdose: a threshold effect","volume":"111","author":"Hiller","year":"2009","journal-title":"Anesthesiology."},{"key":"2019041606593274700_b90-0690199","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/AAP.0b013e31819340be","article-title":"Early use of lipid emulsion to treat incipient mepivacaine intoxication","volume":"34","author":"Charbonneau","year":"2009","journal-title":"Reg Anesth Pain Med."},{"key":"2019041606593274700_b91-0690199","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1213\/ane.0b013e3181683dd7","article-title":"Reversal of central nervous system and cardiac toxicity after local anesthetic intoxication by lipid emulsion injection","volume":"106","author":"Litz","year":"2008","journal-title":"Anesth Analg."},{"key":"2019041606593274700_b92-0690199","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/AAP.0b013e31819a1323","article-title":"Immediate lipid emulsion therapy in the successful treatment of bupivacaine systemic toxicity","volume":"34","author":"Markowitz","year":"2009","journal-title":"Reg Anesth Pain Med."},{"key":"2019041606593274700_b93-0690199","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000542-200607000-00033","article-title":"Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest","volume":"105","author":"Rosenblatt","year":"2006","journal-title":"Anesthesiology."},{"key":"2019041606593274700_b94-0690199","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1213\/01.ANE.0000138550.57760.22","article-title":"Lipid, not propofol, treats bupivacaine overdose","volume":"99","author":"Weinberg","year":"2004","journal-title":"Anesth Analg."},{"key":"2019041606593274700_b95-0690199","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1197\/j.aem.2006.10.094","article-title":"Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline","volume":"14","author":"Bania","year":"2007","journal-title":"Acad Emerg Med."},{"key":"2019041606593274700_b96-0690199","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1553-2712.2008.00313.x","article-title":"Correlation of plasma and peritoneal diasylate clomipramine concentration with hemodynamic recovery after intralipid infusion in rabbits","volume":"16","author":"Harvey","year":"2009","journal-title":"Acad Emerg Med."},{"key":"2019041606593274700_b97-0690199","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1553-2712.2008.00259.x","article-title":"Determining the optimal dose of intravenous fat emulsion for the treatment of severe verapamil toxicity in a rodent model","volume":"15","author":"Perez","year":"2008","journal-title":"Acad Emerg Med."},{"key":"2019041606593274700_b98-0690199","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1197\/j.aem.2005.08.016","article-title":"Intralipid prolongs survival in a rat model of verapamil toxicity","volume":"13","author":"Tebbutt","year":"2006","journal-title":"Acad Emerg Med."},{"key":"2019041606593274700_b99-0690199","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.annemergmed.2007.06.004","article-title":"Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine","volume":"51","author":"Sirianni","year":"2008","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b100-0690199","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1197\/j.aem.2007.04.006","article-title":"Hemodynamic effects of intralipid after verapamil intoxication may be due to a direct effect of fatty acids on myocardial calcium channels","volume":"14","author":"Gueret","year":"2007","journal-title":"Acad Emerg Med."},{"key":"2019041606593274700_b101-0690199","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/AAP.0b013e3181c6f5aa","article-title":"Safety of high volume lipid emulsion infusion: a first approximation of LD50 in rats","volume":"35","author":"Hiller","year":"2010","journal-title":"Reg Anesth Pain Med."},{"key":"2019041606593274700_b102-0690199","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/0140-6736(90)91388-Q","article-title":"Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine","volume":"335","author":"Harrison","year":"1990","journal-title":"Lancet."},{"key":"2019041606593274700_b103-0690199","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199106273242604","article-title":"Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure","volume":"324","author":"Harrison","year":"1991","journal-title":"N Engl J Med."},{"key":"2019041606593274700_b104-0690199","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/bmj.303.6809.1026","article-title":"Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial","volume":"303","author":"Keays","year":"1991","journal-title":"BMJ."},{"key":"2019041606593274700_b105-0690199","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bmj.2.6198.1097","article-title":"Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning","volume":"2","author":"Prescott","year":"1979","journal-title":"Br Med J."},{"key":"2019041606593274700_b106-0690199","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1542\/peds.55.6.871","article-title":"Acetaminophen poisoning and toxicity","volume":"55","author":"Rumack","year":"1975","journal-title":"Pediatrics."},{"issue":"(5, pt 2, suppl)","key":"2019041606593274700_b107-0690199","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1542\/peds.62.5S.898","article-title":"Acetaminophen overdose: incidence, diagnosis, and management in 416 patients","volume":"62","author":"Rumack","year":"1978","journal-title":"Pediatrics."},{"key":"2019041606593274700_b108-0690199","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study (1976 to 1985)","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N Engl J Med."},{"key":"2019041606593274700_b109-0690199","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJM199411103311913","article-title":"Acetaminophen poisoning and liver function","volume":"331","author":"Smilkstein","year":"1994","journal-title":"N Engl J Med."},{"key":"2019041606593274700_b110-0690199","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/MEG.0b013e32831f1f3a","article-title":"N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress","volume":"21","author":"Galicia-Moreno","year":"2009","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2019041606593274700_b111-0690199","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0378-4274(94)90202-X","article-title":"N-acetyl cysteine is an early but also a late preventive agent against carbon tetrachloride-induced liver necrosis","volume":"71","author":"Valles","year":"1994","journal-title":"Toxicol Lett."},{"key":"2019041606593274700_b112-0690199","first-page":"1044","article-title":"Use of acetylcysteine as the life-saving antidote in Amanita phalloides (death cap) poisoning. Case report on 11 patients","volume":"49","author":"Montanini","year":"1999","journal-title":"Arzneimittelforschung."},{"key":"2019041606593274700_b113-0690199","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13181-010-0071-0","article-title":"Acute chloroform ingestion successfully treated with intravenously administered N-acetylcysteine","volume":"6","author":"Dell\u2019Aglio","year":"2010","journal-title":"J Med Toxicol."},{"key":"2019041606593274700_b114-0690199","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-124-8-199604150-00004","article-title":"Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature","volume":"124","author":"Anderson","year":"1996","journal-title":"Ann Intern Med."},{"key":"2019041606593274700_b115-0690199","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.annemergmed.2009.05.010","article-title":"Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning","volume":"54","author":"Yarema","year":"2009","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b116-0690199","volume-title":"Acetadote (acetylcysteine) injection package insert","year":"2011"},{"key":"2019041606593274700_b117-0690199","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/bmj.280.6206.46-b","article-title":"Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning","volume":"280","author":"Prescott","year":"1980","journal-title":"Br Med J."},{"key":"2019041606593274700_b118-0690199","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/15563650.2010.513336","article-title":"A multicenter comparison of the safety of oral versus intravenous acetylcysteine for treatment of acetaminophen overdose","volume":"48","author":"Heard","year":"2010","journal-title":"Clin Toxicol (Phila)."},{"key":"2019041606593274700_b119-0690199","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMct0708278","article-title":"Acetylcysteine for acetaminophen poisoning","volume":"359","author":"Heard","year":"2008","journal-title":"N Engl J Med."},{"key":"2019041606593274700_b120-0690199","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/15563659709001226","article-title":"Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity","volume":"35","author":"Horowitz","year":"1997","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606593274700_b121-0690199","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0196-0644(05)81354-X","article-title":"Trans-placental transport of N-acetylcysteine in an ovine model","volume":"20","author":"Selden","year":"1991","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b122-0690199","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.annemergmed.2007.01.015","article-title":"Patient-tailored acetylcysteine administration","volume":"50","author":"Dart","year":"2007","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b123-0690199","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(73)91879-5","article-title":"Treatment of drug overdosage with naloxone, a specific narcotic antagonist","volume":"1","author":"Evans","year":"1973","journal-title":"Lancet."},{"key":"2019041606593274700_b124-0690199","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bmj.2.5868.717-a","article-title":"Use of naloxone in opiate poisoning","volume":"2","author":"Evans","year":"1973","journal-title":"Br Med J."},{"key":"2019041606593274700_b125-0690199","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/j.1552-4604.1987.tb02191.x","article-title":"Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist","volume":"27","author":"Dixon","year":"1987","journal-title":"J Clin Pharmacol."},{"key":"2019041606593274700_b126-0690199","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/bja\/74.1.73","article-title":"Actions of morphine on noradrenaline efflux in the rat locus coeruleus are mediated via both opioid and alpha 2 adrenoceptor mechanisms","volume":"74","author":"Jorm","year":"1995","journal-title":"Br J Anaesth."},{"key":"2019041606593274700_b127-0690199","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1081\/CLT-120004402","article-title":"Clonidine toxicity revisited","volume":"40","author":"Seger","year":"2002","journal-title":"J Toxicol Clin Toxicol."},{"key":"2019041606593274700_b128-0690199","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006565-200002000-00012","article-title":"Central nervous system manifestations of an ibuprofen overdose reversed by naloxone","volume":"16","author":"Easley","year":"2000","journal-title":"Pediatr Emerg Care."},{"key":"2019041606593274700_b129-0690199","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0736-4679(01)00438-3","article-title":"Use of naloxone in valproic acid overdose: case report and review","volume":"22","author":"Roberge","year":"2002","journal-title":"J Emerg Med."},{"key":"2019041606593274700_b130-0690199","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/emj.2007.049791","article-title":"Chronic valproic acid intoxication: reversal by naloxone","volume":"24","author":"Thanacoody","year":"2007","journal-title":"Emerg Med J."},{"key":"2019041606593274700_b131-0690199","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0196-0644(05)81389-7","article-title":"Naloxone reversal of hypotension due to captopril overdose","volume":"20","author":"Varon","year":"1991","journal-title":"Ann Emerg Med."},{"issue":"(suppl 1)","key":"2019041606593274700_b132-0690199","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1191\/0269216306pm1126oa","article-title":"Opioid-induced respiratory effects: new data on buprenorphine","volume":"20","author":"Dahan","year":"2006","journal-title":"Palliat Med."},{"key":"2019041606593274700_b133-0690199","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology."},{"key":"2019041606593274700_b134-0690199","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/978-0-387-73693-8_85","article-title":"Nalox-one reversal of opioid-induced respiratory depression with special emphasis on the partial agonist\/antagonist buprenorphine","volume":"605","author":"Sarton","year":"2008","journal-title":"Adv Exp Med Biol."},{"key":"2019041606593274700_b135-0690199","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200607000-00012","article-title":"Naloxone reversal of buprenorphine-induced respiratory depression","volume":"105","author":"Van Dorp","year":"2006","journal-title":"Anesthesiology."},{"key":"2019041606593274700_b136-0690199","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003088-200746110-00004","article-title":"Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone: a study in healthy volunteers","volume":"46","author":"Yassen","year":"2007","journal-title":"Clin Pharmacokinet."},{"key":"2019041606593274700_b137-0690199","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0196-0644(86)80994-5","article-title":"A dosing nomogram for continuous infusion intravenous naloxone","volume":"15","author":"Goldfrank","year":"1986","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b138-0690199","first-page":"752","article-title":"Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses","volume":"76","author":"Boyle","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"2019041606593274700_b139-0690199","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.annemergmed.2007.06.493","article-title":"Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia","volume":"51","author":"Fasano","year":"2008","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b140-0690199","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03161009","article-title":"Case files of the medical toxicology fellowship training program at the children\u2019s hospital of Philadelphia: a pediatric exploratory sulfonylurea ingestion","volume":"2","author":"Calello","year":"2006","journal-title":"J Med Toxicol."},{"key":"2019041606593274700_b141-0690199","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1067\/mem.2000.108183","article-title":"Octreotide: an antidote for sulfonylurea-induced hypoglycemia","volume":"36","author":"McLaughlin","year":"2000","journal-title":"Ann Emerg Med."},{"key":"2019041606593274700_b142-0690199","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0736-4679(03)00204-X","article-title":"Effectiveness of octreotide in a case of refractory sulfonylurea-induced hypoglycemia","volume":"25","author":"Green","year":"2003","journal-title":"J Emerg Med."},{"key":"2019041606593274700_b143-0690199","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1440-1754.2008.01339.x","article-title":"Octreotide in children with hypoglycaemia due to sulfonylurea ingestion","volume":"44","author":"Rath","year":"2008","journal-title":"J Paediatr Child Health."},{"key":"2019041606593274700_b144-0690199","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/JPEM.2009.22.2.171","article-title":"Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide","volume":"22","author":"Pelavin","year":"2009","journal-title":"J Pediatr Endocrinol."},{"key":"2019041606593274700_b145-0690199","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1345\/aph.1M433","article-title":"Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure","volume":"44","author":"Vallurupalli","year":"2010","journal-title":"Ann Pharmacother."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/3\/199\/28455737\/ajhp0199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T23:05:52Z","timestamp":1742339152000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/3\/199\/5112117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":145,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110014","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,2,1]]},"published":{"date-parts":[[2012,2,1]]}}}